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Human MHC class I antigens are composed of polymorphic HLA-A,B,C H chains
noncovalently associatedwith an invariant L chain, ß2-microglobulin (ß2m) (1). Cell
surface expression of class I antigen requires the intracellular assembly of H and
L chain (1) .
CTLs can only kill tumorcells expressing a tumor-associated neo-antigen ifthese
cells also express MHC class I antigens (2). A relationship between the loss of class
I antigens and increased malignancy is suggested by some reports on class I expres-
sion in human neoplasms, including the eccrine porocarcinoma of the skin (3), B
cell lymphoma (4), melanoma (5), and colon carcinoma (6).
Previous studies (6-8) have shown that colon carcinomas can lack the expression
of the native HLA-A,B,C/ß2m complex in all tumor cells or in a proportion thereof.
The question is unresolved, however, whether the basis of this defect is a coordinate
loss of H chains and ß2m, or whether the expression of one of the two subunits is
selectively abrogated. We investigated the expression of uncomplexed H chain and
ß2m in the colon carcinomas, which had been found to be deficient for the two-chain
molecule in a previous screening of 200 cases (6, 7). The paper describes the exclu-
sive loss of ß2m protein and mRNA by the tumor cells in all 15 carcinomas studied.
Materials and Methods
BriefDefinitive Report
Antibodies.
￿
Mouse mAbs with the following specificities were used: W6/32 (9) and B.9.12.1
(10) against nonpolymorphic combinatorial determinants of the HLA-A,B,C/ß2m complex;
BBMA (11) and B.1.G.6 (10) against free or complexed ß2m; and HC-10 (12) against a deter-
minant present on free HLA-B and HLA-C H chains. Additionally, a polyclonal rabbit an-
tiserum (RaHC) recognizing free HLA-A, -B and -C H chains (12) was used. mAbs W6/32
and BBMA, mAbs B.9.12.1 and B.1.G.6, and RaHC and mAb HC-10 were gifts of Dr. J.
Johnson, Munich, Dr. F Lemonnier, Marseille, and Dr. H. Ploegh, Amsterdam,respectively.
Immunbhistological Staining.
￿
Immunohistochemical staining was performed as previously
described (6). Briefly, acetone-fixed serial 5-gm frozen sections of selected colon carcinomas
(a gift of Dr. P M611er, Heidelberg) were incubated for 1 h with purified mouse mAbs at
10 ltg/ml, diluted ascitic fluid in case of HC-10, or rabbit anti-H chain antiserum, respec-
tively. The sections were subsequently incubated with rabbit anti-mouse IgG + IgM (a gift
of Dr. G. Moldenhauer, Heidelberg), which was omitted in case of the rabbit antiserum,
swineanti-rabbit IgG (Dako Corp., Copenhagen, Denmark), and peroxidase antiperoxidase
complex (Dako Corp.) for 30 min each. Incubations were carried out in a humid chamber
at room temperature followed by a 10-min wash with PBS. The binding ofantibody was visual-
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ized by incubating with aminoethylcarbazole/H202 substrate solution for 10 min. The sec-
tions were counterstained with hemalum and mounted.
RNA Probes.
￿
A 250-bp Pst I/Sac I fragment of HLA-B8 cDNA (a gift of Dr. E. Weiss,
Munich) cloned into pGEM3 and a 600-bp Sac I/Hind III fragment of human ß2m cDNA
(a gift of Dr. J. Burckhardt, Karlsruhe) cloned into pGEM7 were transcribed into "S-ATP-
labeled antisense RNA using the T7 promoter present in pGEM3 and pGEM7 according
to the protocol recommended by the manufacturers (Promega Biotec, Heidelberg, FRG).
The probes had a sp act of 108 cpm/gg input plasmid DNA (HLA-B8) and 1.2 x 108 cpm/gg
(02m).
In Situ Hybridization.
￿
The hybridization was essentially carried out as described by Shivers
et al. (13). Briefly, 5-gm frozen sections were placed on poly-L-lysine-coated glass slides, rap-
idly dried on a hot plate, and fixed for 15 min in PBS, 4% paraformaldehyde, 0 .1°70 diethyl-
pyrocarbonate. Pre-hybridization was done overnight at 20°C. For hybridization, sections
were incubated for 65 h, at 37°C, with antisense RNA probe (2 x 105 cpm) in 30 pl hybrid-
ization buffer: 10 mM Tris (pH 7.5), 0.6 M NaCl, 1 mM EDTA, 0.02% Ficoll 400, 0.02%
polyvinyl-pyrrolidone 40, 0.02% BSA, 10% Dextran sulfate, 0.005% yeast tRNA, 0.05%
herring sperm DNA, 0.005% poly(A), and 5 pM cold ribo- and deoxyribonucleotides, 0.05%
sodium pyrophosphate (NaPPi), 10 MM L-methionine, 20 mM 2-ME, and 50% formamide.
After a rinse in 2 x SSC, sections were digested with 20 pg/ml RNAse A (Sigma Chemical
Co., Munich, FRG) for 30 min, 37°C. Subsequently, there were 2 10-min washes at 20°C
in 2 x SSC, 0.05 % NaPPi, 1% sodium thiosulfate, 14 mM 2-ME followed by a 24-h wash
(five changes) using 0.5 x SSC in the latter buffer. Sections were dehydrated, dipped in Kodak
NTB2 nuclear track emulsion, and exposed for 14 d at 4°C.
Results and Discussion
Immunohistological Stainings.
￿
In an indirect immunoperoxidase technique on serial
frozen sections, we used antibodies recognizing (a) the HLA-A,B,C H chain when
complexed with ß2m; (b) free or complexed ß2m; or (c) free class I H chains, respec-
tively (Table I). Using the antibodies W6/32 and B.9.12 .1, which recognize HLA
class I H chains only in the presence of ß2m, the tumor cells of the 15 colon carci-
nomas studied were negative, while non-neoplastic stromal cells intersecting the tumor
islands were markedly stained (Fig. 1 A). Normal colon epithelium occasionally present
adjacent to the tumor masses was always strongly positive for the two-chain complex
(not shown) . Stainings with antibodies BBMA and B.1.G.6 specific for ß2m paral-
leled the stainings with antibodies directed to the two-chain complex (Fig. 1 B), in-
TABLE I
Immunohistological Stainings and In Situ Hybridizations
Colon
carcinoma Cell type
mAb W6/32 and
mAb B .9.12.1
(H chain/02m complex)
Immunohistology
mAb BBM.1 and mAb HC-10
mAb B.1 .G.6 and RaHC
(02m) (free class I H chain)
No. 1-15 Tumor cells - - +
Stromal cells;
normal epithelium + + +
In situ hybridization
Antisense RNA probe
ß2m HLA class I H chain
No. 10, Tumor cells - +
13, and Stromal cells;
15 normal epithelium + +MOMBURG AND KOCH
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FIGURE 1 .
￿
Immunoperoxidase
stainings of serial frozen tissue
sections of a colon adenocarci-
noma (case No. 15) ; counter-
stain ofnuclei . (A)mAbW6/32
recognizing the class I H
chain/ß2m complex strongly
stains the cells in the stroma in-
tersecting the tumor while the
pseudoglandular structures
formed by the tumor cells (7)
are entirely negative. (B) The
staining for 02m with mAb
BBM.1 is superimposable to the
staining with W6/32, indicating
the absence of free or bound
02m from the tumor cell popu-
lation . (C) The tumor cell
cytoplasm is strongly stained
withmAbHC-10, indicating the
presence of great amounts of
free class I H chains . The
stromal cells are more weakly
labeled than thetumor cells . x
100 .
dicating that in none of the cases detectable amounts of free ß2m were present in
the tumor cells . In contrast, antibodies to free H chains labeled the tumor cells in-
tracellularly in all 15 cases(Fig . 1 C) . Cellular components ofthe stromaandnormal
epithelial cells were also clearly stained for- freeH chains . The label oftumor cells,
however, was stronger, which is suggestive for an accumulation of freeH chains in
the ß2m-deficient tumor cells .31 2
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In Situ Hybridizations.
￿
In situ hybridizations were performed with three of these
tumors in order to address the question of whether ß2mmRNA was expressed . 35S_
labeled antisense RNA probes specific for 02m andHLAH chain were used in the
hybridization procedure on formalin-fixed frozen sections . Both probes hybridized
to non-neoplastic stromal cells that serve as an internal positive control for the reac-
tion . In all three cases, the H chain probe strongly hybridized to the tumor cells,
whereas the ß2m probe labeled the tumor cells only at background levels (Fig. 2) .
As expected, normal colon epithelium was labeled with both 02m and H chain
probes (not shown) . By in situ hybridization, however, it cannot be decided whether
this lack of ß2m mRNA is due to down regulation of transcription or to the insta-
bility of the transcripts .
Ourin situ analysis ofcolon carcinomas has to be discussed in thecontext ofprevious
reports on the abrogation ofMHC class I antigen expression by neoplastic cells in
vitro . The Burkitt lymphoma cell line Daudi, which fails to express theH chain/ß2m
complex on the cell surface due to the complete absence ofß2m protein, expresses
ß2m mRNA (14) . This mRNA is, however, not functional due to a mutated initia-
tion codon (15) . The mutant mouse thymoma cell line RIE lacks 02m due to genetic
defects in both ß2m genes . Low levels ofH-2K/D have been detected at the cell sur-
face of RlE cells after transfection of the ß2m gene (16, 17) . In human small cell
lung cancer (18) and melanoma cell lines (19), a coordinate low level ofH chain and
ß2m transcription and translation has been found, which could be considerably in-
creased by IFN treatment . The mouse teratocarcinoma cell line F9 has been found
FIGURE 2 . In situ hybridiza-
tions ofserial frozen sections of
colon carcinoma No. 15 ; no
counterstain . Grains appear at
the sites of tissue-bound 35S-
labeled antisense RNA probe .
(A)The 02m-specific probe hy-
bridizes markedly to cells in the
tumor stroma (compare with
Fig. 1 B) while it binds to the
tumor structures (7) only at
background density as it was es-
timated by comparison with
control sections pretreated with
RNAse before hybridization
(not shown). (B) In contrast, the
HLA H chain-specific RNA
probe strongly hybridizes to the
carcinoma cells (compare with
Fig. 1 C) . Stromal cells are less
densely labeled . x 60.MOMBURG AND KOCH
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to have a transcriptional block of both H chain and ß2m mRNAs but transcription
was achieved when differentiation was induced with retinoic acid (20). The chorio-
carcinoma cell line JaR (21) and certain neuroblastoma cell lines (22) provide ex-
amples for tumor cells that contain ß2m in the absence of detectable HLA H chains.
Hence, a selective loss of 02m expression has only been reported for the in vitro
cell lines Daudi and RIE. Our results, however, give evidence for a surprisingly high
frequency of ß2m-deficient human colon carcinomas. The detection of such ß2m-
deficient tumors in vivo excludes the objection that such defects leading to an HLA-
phenotype of tumor cells arise artificially during long-term cell culture. Other human
tumors that were reported for loss ofthe two-chain complex remain to be investigated
for the presence of 02m and free H chain.
MHC class I deficiency may provide a selective advantage to tumor cells, since
it may facilitateescape from antitumor immune attack mediated by cytotoxic T cells.
According to present knowledge, ß2m is required for post-translational processing
and transport to the cell surface of all HLA-A, -B, and -C gene products (12, 23) .
Therefore, the exclusive abrogation of its expression appears to be a very efficient
mechanism for eliminating the restriction elements required by cytotoxic T cells
for the recognition and destruction of tumor cells.
Summary
Expression of MHC class I antigens requires the intracellular assembly of HLA-
A,B,C H chains and ß2-microglobulin (ß2m). We have investigated the expression
of free H chain, ß2m, and their mRNAs in tissue sections of colon carcinomas that
were defective for the native two-chain molecule. In all of these tumors, ß2m pro-
tein and mRNA were found to be completely absent from the neoplastic cells, whereas
free H chains and their respective mRNAs were present in abundance in the tumor
cell cytoplasm. The selective abrogation of 02m expression represents a unique
mechanism leading to a complete loss of class I antigen surface expression in vivo.
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